PRF1 and cancer: Their ability to detect and eliminate tumour cells through mechanisms such as perforin- and granzyme-mediated cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) makes them attractive for cancer immunotherapy [1,2,3].